Cliff Kerr

Dr. Cliff Kerr


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2021 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
CKCliff Kerr
Cliff Kerr
RSRobyn M. Stuart
Robyn M. Stuart
DMDina Mistry
Dina Mistry
RARomesh Abeysuriya
Romesh Abeysuriya
KRKatherine Rosenfeld
Katherine Rosenfeld
DKDaniel J. Klein
Daniel J. Klein
The COVID-19 pandemic has created an urgent need for models that can project epidemic trends, explore intervention scenarios, and estimate resource needs. Here we describe the methodology of Covasim (COVID-19 Agent-based Simulator), an open-source model developed to help address these questions. Covasim includes country-specific demographic information on age structure and population size; realistic transmission networks in different social layers, including households, schools, workplaces, long-term care facilities, and communities; age-specific disease outcomes; and intrahost viral dynamics, including viral-load-based transmissibility. Covasim also supports an extensive set of interventions, including non-pharmaceutical interventions, such as physical distancing and protective equipment; pharmaceutical interventions, including vaccination; and testing interventions, such as symptomatic and asymptomatic testing, isolation, contact tracing, and quarantine. These interventions can incorporate the effects of delays, loss-to-follow-up, micro-targeting, and other factors. Implemented in pure Python, Covasim has been designed with equal emphasis on performance, ease of use, and flexibility: realistic and highly customized scenarios can be run on a standard laptop in under a minute. In collaboration with local health agencies and policymakers, Covasim has already been applied to examine epidemic dynamics and inform policy decisions in more than a dozen countries in Africa, Asia-Pacific, Europe, and North America.

18 August 2016 in BMC Neuroscience
Verified
Journal Article
Open access
TEthe EyeWirers
the EyeWirers
TSTatyana O. Sharpee
Tatyana O. Sharpee
ADAlain Destexhe
Alain Destexhe
MKMitsuo Kawato
Mitsuo Kawato
VSVladislav Sekulić
Vladislav Sekulić
KCKarishma Chhabria
Karishma Chhabria
A1 Functional advantages of cell-type heterogeneity in neural circuits

20 May 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
CKCliff Kerr
Cliff Kerr
DMDina Mistry
Dina Mistry
RSRobyn M. Stuart
Robyn M. Stuart
KRKatherine Rosenfeld
Katherine Rosenfeld
GHGregory R. Hart
Gregory R. Hart
DKDaniel J. Klein
Daniel J. Klein
Initial COVID-19 containment in the United States focused on limiting mobility, including school and workplace closures. However, these interventions have had enormous societal and economic costs. Here, we demonstrate the feasibility of an alternative control strategy, test-trace-quarantine: routine testing of primarily symptomatic individuals, tracing and testing their known contacts, and placing their contacts in quarantine. We perform this analysis using Covasim, an open-source agent-based model, which has been calibrated to detailed demographic, mobility, and epidemiological data for the Seattle region from January through June 2020. With current levels of mask use and schools remaining closed, we find that high but achievable levels of testing and tracing are sufficient to maintain epidemic control even under a return to full workplace and community mobility and with low vaccine coverage. The easing of mobility restrictions in June 2020 and subsequent scale-up of testing and tracing programs through September provided real-world validation of our predictions. Although we show that test-trace-quarantine can control the epidemic in both theory and practice, its success is contingent on high testing and tracing rates, high quarantine compliance, relatively short testing and tracing delays, and moderate to high mask use. Thus, in order for test-trace-quarantine to control transmission with a return to high mobility, strong performance in all aspects of the program is required.

15 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
CKCliff Kerr
Cliff Kerr
RSRobyn M. Stuart
Robyn M. Stuart
DMDina Mistry
Dina Mistry
RARomesh G. Abeysuriya
Romesh G. Abeysuriya
KRKatherine Rosenfeld
Katherine Rosenfeld
DKDaniel J. Klein
Daniel J. Klein
The COVID-19 pandemic has created an urgent need for models that can project epidemic trends, explore intervention scenarios, and estimate resource needs. Here we describe the methodology of Covasim (COVID-19 Agent-based Simulator), an open-source model developed to help address these questions. Covasim includes country-specific demographic information on age structure and population size; realistic transmission networks in different social layers, including households, schools, workplaces, long-term care facilities, and communities; age-specific disease outcomes; and intrahost viral dynamics, including viral-load-based transmissibility. Covasim also supports an extensive set of interventions, including non-pharmaceutical interventions, such as physical distancing and protective equipment; pharmaceutical interventions, including vaccination; and testing interventions, such as symptomatic and asymptomatic testing, isolation, contact tracing, and quarantine. These interventions can incorporate the effects of delays, loss-to-follow-up, micro-targeting, and other factors. Implemented in pure Python, Covasim has been designed with equal emphasis on performance, ease of use, and flexibility: realistic and highly customized scenarios can be run on a standard laptop in under a minute. In collaboration with local health agencies and policymakers, Covasim has already been applied to examine epidemic dynamics and inform policy decisions in more than a dozen countries in Africa, Asia-Pacific, Europe, and North America.

13 April 2022 in Communications Medicine
Verified
Journal Article
Open access
PDF file
CBCecília Artico Banho
Cecília Artico Banho
Lívia SacchettoLívia Sacchetto
Lívia Sacchetto
GCGuilherme Campos
Guilherme Campos
CBCíntia Bittar
Cíntia Bittar
FPFabio Sossai Possebon
Fabio Sossai Possebon
MNMauricio Nogueira
Mauricio Nogueira
Background: The emergence of the Brazilian variant of concern, Gamma lineage (P.1), impacted the epidemiological profile of COVID-19 cases due to its higher transmissibility rate and immune evasion ability. Methods: We sequenced 305 SARS-CoV-2 whole-genomes and performed phylogenetic analyses to identify introduction events and the circulating lineages. Additionally, we use epidemiological data of COVID-19 cases, severe cases, and deaths to measure the impact of vaccination coverage and mortality risk. Results: Here we show that Gamma introduction in São José do Rio Preto, São Paulo, Brazil, was followed by the displacement of seven circulating SARS-CoV-2 variants and a rapid increase in prevalence two months after its first detection in January 2021. Moreover, Gamma variant is associated with increased mortality risk and severity of COVID-19 cases in younger age groups, which corresponds to the unvaccinated population at the time. Conclusions: Our findings highlight the beneficial effects of vaccination indicated by a pronounced reduction of severe cases and deaths in immunized individuals, reinforcing the need for rapid and massive vaccination.

1 March 2017 in IBM Journal of Research and Development
Verified
Journal Article
Closed access
SDSalvador Dura-Bernal
Salvador Dura-Bernal
SNS. A. Neymotin
S. A. Neymotin
CKCliff Kerr
Cliff Kerr
SSS. Sivagnanam
S. Sivagnanam
AMAmit Majumdar
Amit Majumdar
WLWilliam Lytton
William Lytton
Biomimetic simulation permits neuroscientists to better understand the complex neuronal dynamics of the brain. Embedding a biomimetic simulation in a closed-loop neuroprosthesis, which can read and write signals from the brain, will permit applications for amelioration of motor, psychiatric, and memory-related brain disorders. Biomimetic neuroprostheses require real-time adaptation to changes in the external environment, thus constituting an example of a dynamic data-driven application system. As model fidelity increases, so does the number of parameters and the complexity of finding appropriate parameter configurations. Instead of adapting synaptic weights via machine learning, we employed major biological learning methods: spike-timing dependent plasticity and reinforcement learning. We optimized the learning metaparameters using evolutionary algorithms, which were implemented in parallel and which used an island model approach to obtain sufficient speed. We employed these methods to train a cortical spiking model to utilize macaque brain activity, indicating a selected target, to drive a virtual musculoskeletal arm with realistic anatomical and biomechanical properties to reach to that target. The optimized system was able to reproduce macaque data from a comparable experimental motor task. These techniques can be used to efficiently tune the parameters of multiscale systems, linking realistic neuronal dynamics to behavior, and thus providing a useful tool for neuroscience and neuroprosthetics.